Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

OCULAR THERAPEUTIX, INC

OCUL · Nasdaq · CIK 0001393434 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

23 Form 4 transaction lines observed in the same window
13 sales · 10 option, withholding, award, gift or other lines

Last qualifying purchase2026-02-20 · LINDSTROM RICHARD L MD · $461.4K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Dugel PravinSee Remarks
▼○○▼○
Kaiser PeterChief Development Officer
▼▼▼
Heier Jeffrey S.Chief Scientific Officer
▼▼▼
Nayak SanjayChief Strategy Officer
▼▼
Williams Leslie J.Director
○
Warden Charles MDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 8 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-02-20 · LINDSTROM RICHARD L MD.

Recent Form 4 activity

1Purchases
29Sales
21Other Form 4 lines
47SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING13 sale line(s) · context only
OTHER10 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
29,412,673
Previous report
29,933,140
Avg daily volume
4,057,160
Days to cover
7.2

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-02-20LINDSTROM RICHARD L MDPurchase (P)Common Stock60,229USD 7.66USD 461,354SEC filing ↗
2025-05-08LINDSTROM RICHARD L MDPurchase (P)Common Stock10,000USD 6.96USD 69,600SEC filing ↗
2024-02-26SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share930,851USD 7.52USD 7,000,000SEC filing ↗
2023-12-14SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share1,538,461USD 3.25USD 4,999,998SEC filing ↗
2023-08-30Mattessich Antony C.Purchase (P)Common Stock6,500USD 3.81USD 24,765SEC filing ↗
2022-11-07SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share7,328USD 3.50USD 25,648SEC filing ↗
2022-10-11SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share10,000USD 3.90USD 39,000SEC filing ↗
2022-10-10SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share10,000USD 4.00USD 40,000SEC filing ↗
2022-09-29SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share18,800USD 4.04USD 75,952SEC filing ↗
2022-09-28SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share1,200USD 4.10USD 4,920SEC filing ↗
2022-09-27SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share130,000USD 4.68USD 608,400SEC filing ↗
2022-05-12Heier Jeffrey S.Purchase (P)Common Stock15,000USD 3.05USD 45,750SEC filing ↗
2022-02-23SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share10,000USD 4.80USD 48,000SEC filing ↗
2022-02-18SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share40,000USD 5.00USD 200,000SEC filing ↗
2022-01-28SUMMER ROAD LLCPurchase (P)Common Stock, $0.0001 par value per share4,023USD 5.20USD 20,920SEC filing ↗

Form 4 evidence

51 transaction lines in the latest 365-day window; 206 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-08Anderman ToddSale (S)Common Stock11,984USD 7.29USD 87,363SEC filing ↗
2026-10-02Kaiser PeterSale (S)Common Stock9,990USD 7.05USD 70,430SEC filing ↗
2026-10-02Heier Jeffrey S.Sale (S)Common Stock10,869USD 7.05USD 76,626SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-08Anderman ToddSale (S)Common Stock11,984USD 7.29USD 87,363SEC filing ↗
2026-10-02Kaiser PeterSale (S)Common Stock9,990USD 7.05USD 70,430SEC filing ↗
2026-10-02Heier Jeffrey S.Sale (S)Common Stock10,869USD 7.05USD 76,626SEC filing ↗
2026-08-31Notman DonaldSale (S)Common Stock1,099USD 10.24USD 11,254SEC filing ↗
2026-08-25Dugel PravinGift (G)Common Stock50,092USD 0.00USD 0SEC filing ↗
2026-08-24Nayak SanjaySale (S)Common Stock1,897USD 10.78USD 20,450SEC filing ↗
2026-08-24Kaiser PeterSale (S)Common Stock3,035USD 10.77USD 32,687SEC filing ↗
2026-08-24Heier Jeffrey S.Sale (S)Common Stock3,296USD 10.78USD 35,531SEC filing ↗
2026-08-24Dugel PravinSale (S)Common Stock21,649USD 10.77USD 233,160SEC filing ↗
2026-06-16Dugel PravinGift (G)Common Stock50,092USD 0.00USD 0SEC filing ↗
2026-06-10Williams Leslie J.Award / grant (A)Common Stock14,000USD 0.00USD 0SEC filing ↗
2026-06-10Warden Charles MAward / grant (A)Common Stock14,000USD 0.00USD 0SEC filing ↗
2026-06-10Robins Jason ShandAward / grant (A)Common Stock15,441USD 0.00USD 0SEC filing ↗
2026-06-10RAINES MERILEEAward / grant (A)Common Stock14,000USD 0.00USD 0SEC filing ↗
2026-06-10LINDSTROM RICHARD L MDAward / grant (A)Common Stock14,000USD 0.00USD 0SEC filing ↗
2026-06-10Hong Seung SuhAward / grant (A)Common Stock14,000USD 0.00USD 0SEC filing ↗
2026-06-10Graves Adrienne LAward / grant (A)Common Stock14,000USD 0.00USD 0SEC filing ↗
2026-06-03Waheed NadiaSale (S)Common Stock14,828USD 8.27USD 122,628SEC filing ↗
2026-05-28Dugel PravinGift (G)Common Stock394,696USD 0.00USD 0SEC filing ↗
2026-05-26Nayak SanjaySale (S)Common Stock1,858USD 8.20USD 15,236SEC filing ↗
2026-05-26Kaiser PeterSale (S)Common Stock2,967USD 8.20USD 24,329SEC filing ↗
2026-05-26Heier Jeffrey S.Sale (S)Common Stock3,018USD 8.20USD 24,748SEC filing ↗
2026-05-26Dugel PravinSale (S)Common Stock21,156USD 8.20USD 173,479SEC filing ↗
2026-04-09Dugel PravinGift (G)Common Stock394,696USD 0.00USD 0SEC filing ↗
2026-02-23Nayak SanjaySale (S)Common Stock1,759USD 8.28USD 14,565SEC filing ↗
2026-02-23Kaiser PeterSale (S)Common Stock2,810USD 8.28USD 23,267SEC filing ↗
2026-02-23Heier Jeffrey S.Sale (S)Common Stock3,057USD 8.28USD 25,312SEC filing ↗
2026-02-23Dugel PravinSale (S)Common Stock20,056USD 8.28USD 166,064SEC filing ↗
2026-02-20Waheed NadiaSale (S)Common Stock3,510USD 7.74USD 27,167SEC filing ↗
2026-02-20LINDSTROM RICHARD L MDPurchase (P)Common Stock60,229USD 7.66USD 461,354SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerOCUL
CIK0001393434
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history206 transaction lines from 2020-01-02 to 2026-10-08
40 P purchase lines · 74 S sale lines · 92 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.